IMB Dx, Inc. products

Cell-free DNA (cfDNA) is circulating fragments of DNA that is released from cells into the circulatory system throughout the body. Tumor cells also release DNA into the blood stream, which is called circulation-tumor DNA(ctDNA). IMBdx Inc.’s AlphaLiquid® platform offers industry-leading ctDNA-based precision diagnostics solutions across the full continuum of cancer care, from therapy selection(AlphaLiquid® 10/100/500) to recurrence and minimal residual disease(MRD) monitoring (AlphaLiquid® Detect), and early stage screening (AlphaLiquid® Screening).